IBM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
IBM is not a strong buy for a beginner, long-term investor at this moment. Despite strong financial performance and positive congressional sentiment, the stock faces significant AI disruption risks, bearish technical indicators, and mixed analyst ratings. The recent 22% selloff and lack of strong trading signals suggest waiting for more stability before investing.
The MACD is positive and expanding, indicating bullish momentum. However, the RSI is neutral, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key resistance is at $256.212, with support at $225.912. The stock is trading near resistance, which may limit upside potential in the short term.
Strong financial performance in Q4 2025, with revenue up 12.15% YoY and net income up 92.14% YoY.
Positive congressional sentiment with significant purchase transactions.
UBS upgrade to Neutral, citing balanced risk/reward after the recent selloff.
Significant AI disruption risks due to generative AI advancements, particularly impacting IBM's mainframe business.
Recent 22% stock selloff and extreme volatility in software services peers.
Bearish technical indicators and lack of strong trading signals.
IBM's Q4 2025 financials showed strong growth: Revenue increased by 12.15% YoY to $19.69 billion, net income surged 92.14% YoY to $5.6 billion, and EPS rose 90.29% YoY to $5.88. Gross margin improved to 60.59%, up 1.88% YoY.
Analyst sentiment is mixed. Morgan Stanley lowered its price target to $247, citing AI disruption risks, while UBS upgraded the stock to Neutral, highlighting balanced risk/reward. Jefferies maintains a Buy rating with a $370 target, emphasizing hybrid cloud and AI momentum. However, Erste Group downgraded the stock to Hold, citing slowing growth in key segments.
